By: IPP Bureau
Last updated : November 17, 2025 3:44 pm
Consolidated revenue from operations stood at Rs. 111.05 crore
Remedium Lifecare Limited announced its consolidated financial results for the quarter and half-year ended September 30, 2025.
During the quarter ended September 30, 2025, the consolidated financial results reflect strong operational momentum. Consolidated revenue from operations stood at Rs. 111.05 crore, with total income reaching Rs. 114.31 crore. The quarter recorded a consolidated profit before tax of Rs. 10.43 crore and a profit after tax of Rs. 8.62 crore, with earnings per share of Rs. 0.10 which has doubled compared to Q1 FY26.
For the half year ended September 30, 2025, consolidated revenue from operations was Rs. 224.42 crore and total income stood at Rs. 231.15 crore. Profit before tax for the half year was Rs. 16.14 crore, while profit after tax stood at Rs. 13.27 crore, translating to an earnings per share of Rs. 0.15. Consolidated total assets as on September 30, 2025 amounted to Rs. 1.623.18 crore.
Commenting on the financial performance, Adarsh Munjal, Whole-Time Director, said: "The second quarter results reflect our continued commitment to operational discipline and business expansion. Our consolidated performance demonstrates the strength of our portfolio and our ability to scale efficiently. We are confident that this momentum will continue through the remainder of the financial year as we focus on improving profitability, strengthening our asset position, and driving sustainable growth for all stakeholders."
Remedium Lifecare has recently reinforced its leadership structure with the appointment of Rambhajan Vishwakarma and Vignesh Laxman Gawde on the Board, signifying a renewed focus on governance, global expansion and scaling of CDMO capabilities.